Immunotherapy of Melanoma

Publisher： Bentham Science Publishers

E-ISSN： 1874-4702|9|3|196-207

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.9, Iss.3, 2016-09, pp. : 196-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on Immunotherapy for Melanoma

By Ribas Antoni  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 7, 2006-08 ,pp. : 687-694

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Optimising immunotherapy for malignant melanoma

By  

Inpharma, Vol. 1, Iss. 1262, 2000-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

A Role of Immunotherapy in Metastatic Malignant Melanoma

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 3, 2012-09 ,pp. : 182-188

Bentham Science Publishers

Access to resources Recommend Favorite

Melanoma Immunotherapy: Past, Present, and Future

By  

Current Pharmaceutical Design, Vol. 11, Iss. 27, 2005-10 ,pp. : 3461-3473

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Fundamentals and Rationale for Immunotherapy in Metastatic Melanoma Treatment

By  

Clinical Cancer Drugs, Vol. 2, Iss. 1, 2015-05 ,pp. : 4-15

Bentham Science Publishers

Access to resources Recommend Favorite